Heidi A Browne1, Stefan N Hansen2, Joseph D Buxbaum3, Shannon L Gair1, Judith B Nissen4, Kathrine H Nikolajsen4, Diana E Schendel5, Abraham Reichenberg6, Erik T Parner2, Dorothy E Grice1. 1. Division of Tics, OCD, and Related Disorders, Icahn School of Medicine at Mount Sinai, New York, New York2Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York3Friedman Brain Institute, Icahn School of Medicine at Mount Sin. 2. Department of Public Health, Section for Biostatistics, Aarhus University, Aarhus, Denmark. 3. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York3Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York5Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount. 4. Children and Adolescent Psychiatric Center, Aarhus University Hospital, Aarhus, Denmark. 5. Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark11Department of Economics and Business and National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark12Lundbeck Foundation Initiative for Integra. 6. Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York5Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, New York8Mindich Child Health and Development Institute, Icahn School.
Abstract
IMPORTANCE: Tourette syndrome/chronic tic disorder (TS/CT) and obsessive-compulsive disorder (OCD) overlap in their phenomenological features and often co-occur in affected individuals and families. Understanding how these disorders cluster in families provides important clinical information and is an important step in understanding the causes of these disorders. OBJECTIVE: To determine familial recurrence for TS/CT and OCD using a national epidemiologic sample. DESIGN, SETTING, AND PARTICIPANTS: We performed a population-based study of national health registries in Denmark, including all individuals (n = 1 741 271) born in Denmark from January 1, 1980, through December 31, 2007, and followed up through December 31, 2013. We identified those with TS/CT and/or OCD. MAIN OUTCOMES AND MEASURES: The prevalence of TS/CT and OCD and relative recurrence risk (RRR) for TS/CT or OCD among individuals with an oldest sibling or a parent diagnosed as having TS/CT or OCD compared with individuals without an affected oldest sibling or an affected parent. RESULTS: In this sample, 5596 individuals were diagnosed as having TS/CT; 6191, OCD; and 412, both disorders. The overall cohort prevalence of TS/CT was 0.42% (95% CI, 0.41%-0.43%) and of OCD, 0.84% (95% CI, 0.81%-0.87%). The mean sibling recurrence risk for TS/CT across all birth years was 9.88% (95% CI, 8.02%-12.16%) and for OCD, 4.01% (95% CI, 2.78%-5.76%). The sibling RRR for TS/CT was 18.63 (95% CI, 15.34-22.63). In contrast, the sibling RRR for OCD was 4.89 (95% CI, 3.45-6.93). The parent-offspring RRR for TS/CT was 61.02 (95% CI, 44.43-83.82), whereas the parent-offspring RRR for OCD was 6.25 (95% CI, 4.82-8.11). The sibling and parent-offspring cross-disorder risks were also significant, ranging from 3.20 (95% CI, 2.22-4.62) to 10.27 (95% CI, 5.17-20.39). CONCLUSIONS AND RELEVANCE: Tourette syndrome/CT and OCD cluster in families. The familial aggregation of TS/CT is profound and substantially higher than the familial aggregation for OCD. The recurrence risk estimates provide an important clinical framework for identifying individuals at risk and provide insights into the causes of these disorders.
IMPORTANCE: Tourette syndrome/chronic tic disorder (TS/CT) and obsessive-compulsive disorder (OCD) overlap in their phenomenological features and often co-occur in affected individuals and families. Understanding how these disorders cluster in families provides important clinical information and is an important step in understanding the causes of these disorders. OBJECTIVE: To determine familial recurrence for TS/CT and OCD using a national epidemiologic sample. DESIGN, SETTING, AND PARTICIPANTS: We performed a population-based study of national health registries in Denmark, including all individuals (n = 1 741 271) born in Denmark from January 1, 1980, through December 31, 2007, and followed up through December 31, 2013. We identified those with TS/CT and/or OCD. MAIN OUTCOMES AND MEASURES: The prevalence of TS/CT and OCD and relative recurrence risk (RRR) for TS/CT or OCD among individuals with an oldest sibling or a parent diagnosed as having TS/CT or OCD compared with individuals without an affected oldest sibling or an affected parent. RESULTS: In this sample, 5596 individuals were diagnosed as having TS/CT; 6191, OCD; and 412, both disorders. The overall cohort prevalence of TS/CT was 0.42% (95% CI, 0.41%-0.43%) and of OCD, 0.84% (95% CI, 0.81%-0.87%). The mean sibling recurrence risk for TS/CT across all birth years was 9.88% (95% CI, 8.02%-12.16%) and for OCD, 4.01% (95% CI, 2.78%-5.76%). The sibling RRR for TS/CT was 18.63 (95% CI, 15.34-22.63). In contrast, the sibling RRR for OCD was 4.89 (95% CI, 3.45-6.93). The parent-offspring RRR for TS/CT was 61.02 (95% CI, 44.43-83.82), whereas the parent-offspring RRR for OCD was 6.25 (95% CI, 4.82-8.11). The sibling and parent-offspring cross-disorder risks were also significant, ranging from 3.20 (95% CI, 2.22-4.62) to 10.27 (95% CI, 5.17-20.39). CONCLUSIONS AND RELEVANCE: Tourette syndrome/CT and OCD cluster in families. The familial aggregation of TS/CT is profound and substantially higher than the familial aggregation for OCD. The recurrence risk estimates provide an important clinical framework for identifying individuals at risk and provide insights into the causes of these disorders.
Authors: David Mataix-Cols; Bjarne Hansen; Manuel Mattheisen; Elinor K Karlsson; Anjené M Addington; Julia Boberg; Diana R Djurfeldt; Matthew Halvorsen; Paul Lichtenstein; Stian Solem; Kerstin Lindblad-Toh; Jan Haavik; Gerd Kvale; Christian Rück; James J Crowley Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2019-08-19 Impact factor: 3.568
Authors: A Jeremy Willsey; Thomas V Fernandez; Dongmei Yu; Robert A King; Andrea Dietrich; Jinchuan Xing; Stephan J Sanders; Jeffrey D Mandell; Alden Y Huang; Petra Richer; Louw Smith; Shan Dong; Kaitlin E Samocha; Benjamin M Neale; Giovanni Coppola; Carol A Mathews; Jay A Tischfield; Jeremiah M Scharf; Matthew W State; Gary A Heiman Journal: Neuron Date: 2017-05-03 Impact factor: 17.173
Authors: Marisa N Spann; Laura Timonen-Soivio; Auli Suominen; Keely Cheslack-Postava; Ian W McKeague; Andre Sourander; Alan S Brown Journal: J Am Acad Child Adolesc Psychiatry Date: 2019-02-16 Impact factor: 8.829
Authors: Alden Y Huang; Dongmei Yu; Lea K Davis; Jae Hoon Sul; Fotis Tsetsos; Vasily Ramensky; Ivette Zelaya; Eliana Marisa Ramos; Lisa Osiecki; Jason A Chen; Lauren M McGrath; Cornelia Illmann; Paul Sandor; Cathy L Barr; Marco Grados; Harvey S Singer; Markus M Nöthen; Johannes Hebebrand; Robert A King; Yves Dion; Guy Rouleau; Cathy L Budman; Christel Depienne; Yulia Worbe; Andreas Hartmann; Kirsten R Müller-Vahl; Manfred Stuhrmann; Harald Aschauer; Mara Stamenkovic; Monika Schloegelhofer; Anastasios Konstantinidis; Gholson J Lyon; William M McMahon; Csaba Barta; Zsanett Tarnok; Peter Nagy; James R Batterson; Renata Rizzo; Danielle C Cath; Tomasz Wolanczyk; Cheston Berlin; Irene A Malaty; Michael S Okun; Douglas W Woods; Elliott Rees; Carlos N Pato; Michele T Pato; James A Knowles; Danielle Posthuma; David L Pauls; Nancy J Cox; Benjamin M Neale; Nelson B Freimer; Peristera Paschou; Carol A Mathews; Jeremiah M Scharf; Giovanni Coppola Journal: Neuron Date: 2017-06-21 Impact factor: 17.173
Authors: Behrang Mahjani; Lambertus Klei; Christina M Hultman; Henrik Larsson; Bernie Devlin; Joseph D Buxbaum; Sven Sandin; Dorothy E Grice Journal: Biol Psychiatry Date: 2020-01-22 Impact factor: 13.382